Rapid Micro Biosystems (RPID) Earnings Analysis
Rapid Micro Biosystems (RPID) next reports earnings on 2026-08-11, consensus EPS -0.26 USD. Last quarter (2026-03-12) it missed with EPS -0.28 USD vs -0.23 USD est (-21.7%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -1.86.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does RPID next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.26 USD |
| Revenue estimate | 0.01B |
RPID earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | -0.28 USD | -0.23 USD | -21.7% | Miss |
| 2025-11-07 | -0.26 USD | -0.26 USD | 0% | Beat |
| 2025-05-09 | -0.26 USD | -0.27 USD | +3.7% | Beat |
| 2025-02-28 | -0.22 USD | -0.22 USD | 0% | Beat |
| 2024-11-01 | -0.26 USD | -0.26 USD | 0% | Beat |
| 2024-08-02 | -0.29 USD | -0.28 USD | -3.6% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
RPID valuation and analyst view
| Trailing P/E | -1.86 |
|---|---|
| Trailing EPS | -1.1035 USD |
| Price / book | 4.59 |
| Dividend yield | 0.00% |
| Market cap | 0.09B |
| Analyst consensus | Buy (4 buy / 2 hold / 0 sell) |
| Avg price target | 7 USD |
Related research pages
Frequently asked questions
When is Rapid Micro Biosystems (RPID)'s next earnings date?
Rapid Micro Biosystems is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.26 USD and revenue estimate of 0.01B.
Did RPID beat earnings last quarter?
In its 2026-03-12 report, RPID posted EPS of -0.28 USD versus a -0.23 USD estimate — a miss of 21.7%.
What is RPID's earnings track record?
Over the last 6 reported quarters with consensus data, RPID beat estimates 4 times (67%).
What is RPID's current P/E ratio and EPS?
RPID trades at a trailing P/E of -1.86 on trailing EPS of -1.103495635408 USD.
What do analysts rate RPID?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 7 USD.